StockData
Zenas BioPharma, Inc. logo

Zenas BioPharma, Inc. (ZBIO) stock

ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$27.93−0.08 (-0.29%)

Close on Nov 16, 2026Market cap $1.82BP/E –Yield –

Zenas BioPharma ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for Zenas BioPharma

Zenas BioPharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Zenas BioPharma figures

See a number that looks wrong?